For the year ending 2025-12-31, COLL made $780,567K in revenue. $62,870K in net income. Net profit margin of 8.05%.
| Income Statement | 2025-12-31 | 2024-12-31 | ||
|---|---|---|---|---|
| Product revenues, net | 780,567 | 631,449 | ||
| Intangible asset amortization and impairment | - | 165,304 | ||
| Cost of product revenues (excluding intangible asset amortization) | 95,418 | 88,801 | ||
| Intangible asset amortization | 221,892 | - | ||
| Total cost of product revenues | 317,310 | 254,105 | ||
| Gross profit | 463,257 | 377,344 | ||
| Selling, general and administrative | 284,803 | 210,363 | ||
| Gain on fair value remeasurement of contingent consideration | -1,182 | -2,914 | ||
| Total operating expenses | 283,621 | 207,449 | ||
| Income from operations | 179,636 | 169,895 | ||
| Interest expense | 82,312 | 73,974 | ||
| Interest income | 11,289 | 13,976 | ||
| Loss on extinguishment of debt | -15,994 | -11,329 | ||
| Income before income taxes | 92,619 | 98,568 | ||
| Provision for income taxes | 29,749 | 29,378 | ||
| Net income | 62,870 | 69,190 | ||
| Basic EPS | 1.98 | 2.14 | ||
| Diluted EPS | 1.73 | 1.86 | ||
| Basic Average Shares | 31,706,429 | 32,273,850 | ||
| Diluted Average Shares | 39,701,693 | 40,424,180 | ||
COLLEGIUM PHARMACEUTICAL, INC (COLL)
COLLEGIUM PHARMACEUTICAL, INC (COLL)